SCHEMBL5227953

SCHEMBL5227953

O=C(O)NC1CCC(NC(=O)OCc2ccccc2)C(CO)C1

nearest known ligand 0.55

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.55
GAA P10253 1/20 0.55
CPB1 P15086 2/20 0.54
TSHR P16473 1/20 0.53
TLR4 O00206 1/20 0.47
EPHX1 P07099 1/20 0.47
CTSL P07711 1/20 0.46
CTSB P07858 1/20 0.46
CTSK P43235 1/20 0.46
KDM1A O60341 1/20 0.44
MAOB P27338 1/20 0.44
DPP4 P27487 2/20 0.44
DPP7 Q9UHL4 2/20 0.44
KCNH2 Q12809 1/20 0.44
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
TACR1 P25103 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3738767 1.00 ALDH1A1 (0.55) ALDH1A1GAACPB1TSHRTLR4
SCHEMBL3738774 1.00 ALDH1A1 (0.55) ALDH1A1GAACPB1TSHRTLR4
SCHEMBL5033689 0.87 CPB1 (0.56) ALDH1A1GAACPB1TSHRTLR4
SCHEMBL5033687 0.87 CPB1 (0.56) ALDH1A1GAACPB1TSHRTLR4
SCHEMBL5027125 0.87 ALDH1A1 (0.52) ALDH1A1GAACPB1TSHRTLR4
SCHEMBL3748161 0.87 ALDH1A1 (0.52) ALDH1A1GAACPB1TSHRTLR4
SCHEMBL3733857 0.87 ALDH1A1 (0.52) ALDH1A1GAACPB1TSHRTLR4
SCHEMBL3733860 0.87 ALDH1A1 (0.52) ALDH1A1GAACPB1TSHRTLR4
SCHEMBL27667807 0.87 ALDH1A1 (0.52) ALDH1A1GAACPB1TSHRTLR4
SCHEMBL5769816 0.86 CPB1 (0.53) ALDH1A1GAACPB1TSHRTLR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1656138-A4 SUBSTITUTED CYCLOALKYAMINE DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY BRISTOL MYERS SQUIBB CO (US) 2007-04-18 EP disclosed
EP-1656138-A2 SUBSTITUTED CYCLOALKYAMINE DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY Bristol-Myers Squibb Company (US) 2006-05-17 EP disclosed
WO-2005020899-A2 SUBSTITUTED CYCLOALKYAMINE DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY BRISTOL-MYERS SQUIBB COMPANY (US) 2005-03-10 WO disclosed